Medication info
Neomaryl M Tablet 1/250 mg

Neomaryl M Tablet 1/250 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›1mg / 1 tabletMetformin Hydrochloride›250mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White, oblong film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201107525 · Approved 2011.09.29 · Insurance code 643306120

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this drug 1–2 times daily immediately before or with meals. The dose may be adjusted based on each patient’s current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient’s current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and experience is available with gradual dose escalation based on blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride monotherapy generally provides little additional effect at doses exceeding 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being given in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled dose.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication aids patients with type 2 diabetes in managing their diet and exercise, and allows for more effective blood sugar control by combining glymepiride and metformin. This helps maintain blood sugar levels stably and assists in diabetes treatment.

How to take

Adult dose

Administer this drug 1–2 times daily immediately before or with meals. The dose may be adjusted based on each patient’s current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient’s current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and experience is available with gradual dose escalation based on blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride monotherapy generally provides little additional effect at doses exceeding 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being given in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled dose.

Precautions

This medication is an antidiabetic agent that helps lower blood sugar. However, if kidney function deteriorates rapidly, the drug may accumulate in the body, leading to a dangerous condition called lactic acidosis; therefore, it should not be administered or used with caution in patients with impaired kidney function. If dehydration or severe diarrhea, vomiting, or fever causes a lack of bodily fluids, the intake of this medication should be temporarily stopped, and a consultation with a doctor is required. In addition, patients with cardiovascular diseases or those who have previously experienced a myocardial infarction should be cautious, as the risk of cardiovascular complications may increase with this medication. It is safer for women who are pregnant or potentially pregnant, or breastfeeding, to avoid taking this medication and, if necessary, switch to insulin therapy. This medication can induce hypoglycemia, so blood sugar levels should be frequently monitored, especially during the initial period of use, and immediate action should be taken if hypoglycemic symptoms occur. Symptoms of hypoglycemia include headache, dizziness, fatigue, tremors, and severe hunger, and it is crucial to consume sugar-containing foods if these symptoms appear. Consistent meals and exercise, along with weight management, are required during the use of this medication, and regular tests of blood sugar and kidney function must be conducted. Additionally, this medication can affect blood sugar control when taken with certain medications, so inform your doctor or pharmacist if you are taking other medications. This medication may lower vitamin B12 levels, so it is advisable to check vitamin B12 levels regularly during long-term use. Any severe allergic reactions or skin rashes should be reported to a doctor immediately, and if serious adverse symptoms occur while taking this medication, cessation of the medication and consultation with healthcare professionals are required. Special care is needed when this medication is used for children, the elderly, or those with severely impaired liver function. Finally, caution is necessary when driving or operating machinery due to the risk of hypoglycemia or dizziness.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain, metallic taste, visual impairment, taste disorders, erythema, itching, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, peripheral neuropathy, increased liver enzymes, liver function damage, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency during diarrhea, encephalopathy, alopecia, weight gain, headache, severe hunger, fatigue, sleep, weakness, drowsiness, sleep disorders, instability, aggression, attention deficit, inability to focus, abnormal reactions, depression, confusion, language disorder, aphasia, visual disturbances, tremors, paralysis, sensory disorders, dizziness, loss of self-control, delirium, cerebral convulsions, loss of consciousness, coma, weak respiration, bradycardia, sweating, clammy skin, anxiety, tachycardia, hypertension, palpitations, angina pectoris, deep vein thrombosis, cardiac arrest, rectal carcinoma, abdominal pain, abdominal distension, vomiting, dyspepsia, dizziness, leg edema, benign prostatic hyperplasia, palpitations, vertigo, liver dysfunction, arthralgia, facial edema, erectile dysfunction, facial flushing, gastritis, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White, oblong film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.